Reply to the letter to the editor 'Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area: results of the prospectively randomized GAIN study' by Daly et al

Affiliations

¹ Medicine and Research, German Breast Group, Neu-Isenburg.
² Department of Gynecology and Obstetrics, Klinikum Frankfurt-Hoechst, Frankfurt, Germany.

Comment

J Furlanetto et al. Ann Oncol. 2017.

. 2017 Jun 1;28(6):1400.

doi: 10.1093/annonc/mdx117.

¹ Medicine and Research, German Breast Group, Neu-Isenburg.
² Department of Gynecology and Obstetrics, Klinikum Frankfurt-Hoechst, Frankfurt, Germany.

No abstract available

Comment on

Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area: results of the prospectively randomized GAIN study.
Furlanetto J, Eiermann W, Marmé F, Reimer T, Reinisch M, Schmatloch S, Stickeler E, Thomssen C, Untch M, Denkert C, von Minckwitz G, Lederer B, Nekljudova V, Weber K, Loibl S, Möbus V. Furlanetto J, et al. Ann Oncol. 2016 Nov;27(11):2053-2059. doi: 10.1093/annonc/mdw315. Epub 2016 Aug 8. Ann Oncol. 2016. PMID: 27502721 Clinical Trial.
Reply to 'Higher rate of severe toxicities in obese patients receiving dose-dense (dd) chemotherapy according to unadjusted body surface area: results of the prospectively randomized GAIN study' by J. Furlanetto et al.
Daly LE, Power DG, Ryan AM. Daly LE, et al. Ann Oncol. 2017 May 1;28(5):1161-1162. doi: 10.1093/annonc/mdx055. Ann Oncol. 2017. PMID: 28453698 No abstract available.